{"id": "1339181986930446338", "creation": 1608120841.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "quoted": "1339140316931248128", "text": "\u201cThe move makes @BioNTech_Group\u2019s #vaccine the prime international competitor to #China\u2019s leading developers in their home market. Beijing-based #Sinovac and state-owned group #Sinopharm have already begun expanding manufacturing capacity and distributing vaccines.\u201d \ud83e\udd14#COVID19 https://t.co/yDB2121lCq", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#CHINA", "#SINOVAC", "#SINOPHARM", "#COVID19"]}